219
Participants
Start Date
September 5, 2023
Primary Completion Date
January 21, 2025
Study Completion Date
June 30, 2025
HU6
HU6 is being evaluated for its efficacy in improving liver fat content in subjects with Nonalcoholic Steatohepatitis (NASH)
Placebo
Placebo
Panax Clinical Research, Miami Lakes
Miami Clinical Research, Miami
Advanced Clinical Research, Miami
Century Research, LLC, Miami
Entrust Clinical Research, Miami
Southwest General Healthcare Center, Fort Myers
ABMED Clinical Research Corp., Cape Coral
Synergy Healthcare, Bradenton
Lillestol Research, Fargo
Tandem Clinical Research, Marrero
Mt Olympus Medical Research, Houston
Houston Research Institute, Houston
Texas Liver Institute, San Antonio
IMA Clinical Research-Austin, Austin
Velocity Clinical Research, Los Angeles
Catalina Research Institute, Montclair
ProSciento CRU, Chula Vista
Metro Clinical Trials, San Bernardino
Northern California Research Center, Sacramento
CenExel HRI, Berlin
Rivus Pharmaceuticals, Inc.
INDUSTRY